The DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index.
Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, enteric or other systemic infections, and stress have all been reported to be potential triggers of inflammatory bowel disease (IBD). Although a mechanism of triggering a flare of IBD can be hypothesized for each factor, the associations of these factors with flares of IBD remains confusing. In this review, we analyze the literature that explores these associations. There is some evidence to support an association between NSAID use and flares but little data to associate antibiotic use directly with flares. An important connection between antibiotic use and an exacerbation of symptoms is through the development of Clostridium difficile infections. However, for all enteric infections, including C. difficile, it is unclear whether these infections simply trigger symptoms in patients with IBD that resolve on resolution of the infection, or whether they truly trigger a flare of intestinal inflammation that outlasts the infection. There is a paucity of evidence that other systemic infections trigger flares of IBD. Although there is strong evidence for an association between perceived stress levels and flares, there is a weaker association between a simple accounting of stressful life events and flares. Much of the literature is limited by a lack of adequate control groups and failure to report on base rates in the population under study (i.e., NSAIDs and antibiotic use, occurrence of infections, and stress levels). More large population-based matched cohort or case crossover studies and a continued emphasis on prospective designs are needed to better explore these potential associations. Clinical implications given the current state of knowledge are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is likely because IBD patients are particularly susceptible to the development of bacterial superinfections, especially those caused by Clostridium difficile, Campylobacter, Salmonella, Shigella and Entamoeba histolytica, which represent harmful stimuli that can induce a relapse of the disease in a microenvironment that is already altered[140,141].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [141]
Citations
Cites
Chen, L., Li, N., & Ye, H. (2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,208
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,974
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
(1995) · Cited by 1,270
Pépin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,130
Rodríguez, L. G., & Jick, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91843-0 · Cited by 972
Research works printed but not linked: 9
- Mawdsley JE, 2006, Gut, 55, 1053
- Gravallese EM, 1988, Am J Gastroenterol, 83, 703
- Gurian L, 1983, West J Med, 138, 359
- 10.1001/jama.267.9.1244 · DOI · Paper page
- Gue M, 1997, Am J Physiol, 272, G84
- Kiliaan AJ, 1998, Am J Physiol, 275, G1037
- Simren M, 2002, Am J Gastroenterol, 97, 389, 10.1111/j.1572-0241.2002.05475.x · DOI · Paper page
- Tocchi A, 1997, Ital J Gastroenterol Hepatol, 29, 395
- Levenstein S, 1994, Am J Gastroenterol, 89, 1219
Cited by
Sorted by citations
Epidemiology and risk factors for IBD
Ananthakrishnan, A. N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.34 · Cited by 1,741
ACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,594
“Potential precipitants of UC may include recent smoking cessation (14), nonsteroidal anti-inflammatory drug (NSAID) use (15,16), and enteric infections (17).”
BackgroundACG Clinical Guideline: Management of Crohn's Disease in Adults
Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018) · The American Journal of Gastroenterology · doi:10.1038/ajg.2018.27 · Cited by 1,424
Konturek, P. C., Brzozowski, T., & Konturek, S. J. (2011) · PubMed · Cited by 598
A comprehensive review and update on Crohn's disease
Gajendran, M., Loganathan, P., Catinella, A. P., & Hashash, J. G. (2017) · Disease-a-Month · doi:10.1016/j.disamonth.2017.07.001 · Cited by 553
Metadata
- Authors
- Singh, S., Graff, L. A., & Bernstein, C. N.
- Affiliations
- University of Manitoba (CA)
- Venue
- The American Journal of Gastroenterology
- Published
- 2009-03-31
- Volume
- 104
- Issue
- 5
- Pages
- 1298-1313
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W1983233325
- Cited by
- 181
- References
- 100
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 14 · 2019: 14 · 2018: 5 · 2017: 10 · 2016: 10 · 2015: 12 · 2014: 20 · 2013: 11 · 2012: 8
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- inflammatory bowel disease, disease flares, NSAID use, antibiotic use, Clostridium difficile infection, gastrointestinal infections, systemic infection, stress, life events
- MeSH terms
- Anti-Inflammatory Agents, Non-Steroidal, Anti-Bacterial Agents, Bacterial Infections, Education, Medical, Continuing, Female, Gastrointestinal Diseases, Humans, Male, Prognosis, Recurrence, Sensitivity and Specificity, Stress, Psychological, Inflammatory Bowel Diseases, Incidence, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
